Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) announces that the FDA has agreed to allow the company to modify the primary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE